EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats

Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, Kehinde O Adebiyi, Akpevwe Emmanuel Benson, Olajide Ojo, Jessica Otumara Urowoli, Opeyemi Joshua Alabi, Oluwaremilekun Juliet Ojeriakhi, Mayowa Shekoni

Frontiers in Pharmacology · 08.05.2026 · 17

DOI: 10.3389/fphar.2026.1773609 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.05.2026. Verfasst von Adewunmi Akingbola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccine development has traditionally been a lengthy and resource-intensive process, often struggling to keep pace with rapidly emerging infectious threats. Recent advances in artificial intelligence (AI) offer new opportunities to transform this landscape by enabling faster, more precise, and data-driven approaches to vaccine design. This review examines how AI is being applied across key stages of vaccine development, including antigen discovery, epitope prediction, structural optimisation, immunogenicity assessment, and safety evaluation. We highlight the use of machine learning and deep learning models to analyse large-scale genomic, proteomic, and immunological datasets, allowing for more targeted identification of promising vaccine candidates. While AI-driven approaches show considerable promise, their successful translation into effective vaccines depends on the quality and representativeness of the data used, as well as close integration with experimental and clinical validation. Current challenges include data bias, limited representation of populations from low- and middle-income countries, and the need for transparent and interpretable models that can support regulatory decision-making. By synthesising recent developments and ongoing challenges, this review underscores the potential of AI to complement traditional vaccine development pipelines. When responsibly implemented, AI-based methods may accelerate vaccine innovation, improve global preparedness, and support more equitable responses to future infectious disease outbreaks.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceglobal health preparednessinfectious diseasesmachine learningpandemicsvaccine design

Autor:innen und Institutionen

  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Department of Global Health, African Cancer Institute, Stellenbosch University, Cape Town, South Africa.
  • Department of Biology, Indiana University, Bloomington, IN, United States.
  • Faculty of pharmacy, University of Benin, Benin City, Nigeria.
  • School of Applied Sciences, University of West of England, Bristol, United Kingdom.
  • School of Allied Health Sciences, Anglia Ruskin University, Cambridge, United Kingdom.

Zitieren

APA

Akingbola, A., Adegbesan, A., Adewole, O., Adebiyi, K. O., Benson, A. E., Ojo, O., Urowoli, J. O., Alabi, O. J., Ojeriakhi, O. J., & Shekoni, M. (2026). Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1773609

Vancouver

Akingbola A, Adegbesan A, Adewole O, Adebiyi KO, Benson AE, Ojo O, et al. Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1773609

BibTeX
@article{Akingbola2026,
  author = {Akingbola, Adewunmi and Adegbesan, Abiodun and Adewole, Olajumoke and Adebiyi, Kehinde O and Benson, Akpevwe Emmanuel and Ojo, Olajide and Urowoli, Jessica Otumara and Alabi, Opeyemi Joshua and Ojeriakhi, Oluwaremilekun Juliet and Shekoni, Mayowa},
  title = {Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1773609}
}
Kostenlos starten →